Effects of poly-γ-glutamic acid on serum and brain concentrations of glutamate and GABA in diet-induced obese rats by Lee, Hyesung et al.
Nutrition Research and Practice (Nutr Res Pract) 2010;4(1):23-29
DOI: 10.4162/nrp.2010.4.1.23
Effects of poly-γ-glutamic acid on serum and brain concentrations of glutamate 
and GABA in diet-induced obese rats
Hyesung Lee, Moon-Jeong Chang and Sun-Hee Kim
§
Department of Foods and Nutrition, Kookmin University, 861-1 Jeongneung-dong, Seongbuk-gu, Seoul 136-702, Korea 
Abstract
Poly-gamma-glutamic acid (γ-PGA) is a mucilaginous and biodegradable compound produced by Bacillus subtilis from fermented soybeans, and
is found in the traditional Korean soy product, cheongkukjang. This study was carried out to evaluate the effects of γ-PGA from a food source
on the concentration of the neurotransmitter GABA and its metabolic precursor glutamate in diet-induced obese rats. Eight-week old male Sprague-Dawley
rats (n=60) were used. The rats were divided into two groups and obesity was induced by providing either a 10% control fat or 45% high fat 
diet for 5 weeks. The rats were then blocked into 6 groups and supplemented with a 0.1% γ-PGA diet for 4 weeks. After sacrifice, brain and
serum GABA and glutamate concentrations were analyzed by high performance liquid chromatography with fluorometric detection. The rats fed
the high fat diet had significantly increased body weights. γ-PGA supplementation significantly increased serum concentrations of glutamate and
GABA in the control fat diet groups while this effect was not found in the high fat groups. In the brain, glutamate concentrations were significantly
higher in the γ-PGA supplemented groups both in rats fed the normal and high fat diets than in the no γ-PGA controls. GABA concentrations
showed the same tendency. The results indicated that γ-PGA intake increased GABA concentrations in the serum and brain. However, the effects 
were not shown in obese rats.
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Introduction4)
Glutamate is the principal excitatory neurotransmitter in the 
vertebrate nervous system [1] and gamma-aminobutyric acid 
(GABA) is the most abundant inhibitory neurotransmitter, 
meaning that when it finds its way to its receptor sites, it blocks 
the tendency of that neuron to fire [2,3]. Glutamate is irreversibly 
converted to GABA via the GABA shunt from GABAergic 
neurons by glutamate decarboxylase, which uses proximal 
5’-phosphate as a cofactor [4,5]. 
GABA plays an important role in regulating neuronal 
excitability throughout the nervous system. As a neurotransmitter, 
GABA helps induce relaxation and sleep. It balances the brain 
by inhibiting over-excitation. It is involved in neurological and 
psychiatric disorders such as depression, fear, and anxiety [6]. 
GABA also stimulates the anterior pituitary, leading to higher 
levels of human growth hormone. Growth hormone contributes 
significantly to muscle growth and also prevents the creation of 
fat cells [7]. There have been several clinical studies on GABA 
neurotransmitters for elevating growth hormone levels, which has 
a positive effect on sleep cycles and fat burning capabilities [8]. 
In addition, GABA is responsible for regulating many 
physiological functions such as suppressing high blood pressure, 
decreasing blood triglycerides and cholesterol, and preventing 
obesity, which are highly related to the cardiovascular disease 
[9-12]. Several studies showed that GABA functions in reducing 
an alarming increase in systolic blood pressure in spontaneously 
hypertensive rats [13]. Therefore, changes in levels of GABA 
and glutamate in the brain and serum are probably correlated 
with several neurological diseases as well as cardiovascular 
disease [3]. 
Gamma-PGA is an unusual anionic polypeptide in which 
D-and/or L- glutamic acid units are polymerized via γ-amide 
linkages between α-amino and γ–carboxylic groups [14]. γ-PGA 
is a compound of mucilage produced by Bacillus subtilis in 
fermented soybeans and is found in the traditional Korean soy 
product, cheongkukjang. Because γ-PGA is not a chemically 
synthesized product but exists naturally in foods, it is generally 
regarded as safe. Several studies have shown that γ-PGA is 
helpful in increasing intestinal Ca absorption as well as 
intensifying the strength and content of the femur [15], enhances 
immune-stimulating activity, and potentially improves antitumor 
activity [16].
During the past 20 years there has been a dramatic increase 
in obesity in developed countries. The national data of the Korean 
National Health and Nutrition Examination Survey revealed that 
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Table 1. Composition of experimental diets
1
Ingredients
(g/kg of the diet)
CF HF
Casein 140.00 172.104
Cornstarch 465.692 281.465
Glucose 155.00 106.791
Sucrose 100.00 83.483
Cellulose 50.00 61.554
Butter 30.00 213.904
Cholesterol 0 10.00
Soybean oil 10.00 10.00
Mineral mix
2 35.00 43.088
Vitamin mix
3 10.00 12.311
L-Cysteine 1.80 2.216
Choline bitatrate 2.50 3.08
Tetrabutyric acid 0.008 0.008
Total 1,000 1,000
1 CF:  10%  control  fat  diet,  HF:  45%  high  fat  diet 
2 Mineral  mixture:  AIN-93M  [34]
3 Vitamin  mixture:  AIN-93-Vx  [34]
the rate of obese adults with a body mass index (BMI; kg/m
2) 
of 25 or higher increased from 26% in 1998 to 31.7% in 2007. 
Epidemiological studies indicate that obesity, insulin resistance, 
and diabetes lead to the development of cardiovascular disease 
and increase mortality. Obesity is associated with dyslipidemia, 
which leads to elevated triglycerides and compromised cardiac 
function [17]. Thakker et al. [18] reported that diet-induced obese 
mice developed hyperinsulinemia and insulin resistance. The 
brain has evolved mechanisms for sensing and regulating glucose 
levels in the plasma [19]. Diet influences sympathetic nervous 
system activity and dietary-induced changes in sympathetic 
activity contribute to changes in metabolic rate. Insulin-mediated 
glucose metabolism in the hypothalamus provides a link between 
dietary intake and sympathetic nervous system activity. Hyperin-
sulinemia, a consequence of insulin resistance in obese indivi-
duals, is associated with hypertension [20]. In addition, leptin 
may contribute to obesity-induced cardiovascular complications 
that are possibly associated with impaired leptin receptor 
signaling [11]. One of neurocognitive changes in obese people is 
insufficient sleep. Park et al. [21] reported a negative association 
between sleep duration and body mass index among Korean 
adults and Verona et al. [22] suggested a cause-and-effect relation-
ship between insufficient sleep and obesity in the US population.
Therefore, this study was carried out to investigate the effects 
of γ-PGA on GABA and glutamate concentrations in the brain 
and serum and on obesity. A diet-induced obese rat model was 
produced by providing a diet incorporating 45% of kcal from fat. 
Materials and Methods
Animals
The animals used in this study were 8-week old male 
Sprague-Dawley rats (n=60) weighing 250~330 g, and were 
acquired from Orient Bio Inc, Gyeonggi-do, Korea. Each rat was 
housed in an individual wire cage in a controlled environment 
at 22 ± 1℃, 65 ± 5% relative humidity, and a 12-hour light-dark 
cycle (lights on at 8 a.m.). The cages were cleaned every second 
day. After a week of acclimation, the animals were randomly 
divided into two groups and fed either a high fat diet to induce 
obesity or a normal fat diet as a control for 5 weeks. The animals 
were then divided into six groups of ten rats each using a 
randomized complete block design and provided with diets 
containing 0.1% γ-PGA for 4 weeks. The animals were allowed 
free access to the diets and to deionized water ad libitum. All 
aspects of this study were conducted according to the standards 
of the Animal Ethics Committee of the Institution.
Experimental diets
During the induction period of obesity, the animals were 
provided either a 10% control fat diet or a 45% high fat diet 
(shown in Table 1). After 5 weeks of feeding, the rats were 
divided into the following six groups of ten rats each to 
investigate the effects of γ-PGA supplementation over 4 weeks: 
control fat (control 10% fat with 0% γ-PGA; CC), control fat 
γ-PGA (10% control fat with 0.1% γ-PGA; CP), high fat control 
(45% fat with 0% γ-PGA; HC), high fat PGA (45% fat with 
0.1% γ-PGA; HP), switched from high fat to control fat (45% 
to 10% fat with 0% γ-PGA; HCC), and switched from high fat 
to control fat γ-PGA (45% to 10% fat with 0.1% γ-PGA; HCP). 
The HCC and HCP groups were intended to know the effects 
of short-term feeding of high fat. The γ-PGA was kindly 
provided by Bioleaders, Daejeon, Korea, and its molecular weight 
was approximately 2,700 KDa in acid form. Food consumption 
was recorded every second day.
Animal sacrifice and tissue collection
The unanesthetized animals were sacrificed in random order 
by decapitation after 18-hours of fasting. The brain was rapidly 
removed from the cranium and dissected into the left and right 
brains on an ice-cold plate. The tissues were stored at -50℃ 
until analysis and were analyzed within 7 days of sacrifice. Blood 
samples were collected and centrifuged for 10 min at 3,000 rpm 
and 4℃, and then the supernatants were retained and stored at 
-50℃.
Glutamate and GABA analysis
Brain assay
For the brain analysis, HPLC grade methanol and water were 
obtained from J.T Baker (Phillipsburg, NJ, USA). Citric acid, 
octane sulfonic acid, EDTA, sodium phosphate dibasic, sodium 
phosphate monobasic, potassium cyanide, GABA, L-glutamic Hyesung Lee et al. 25
acid, and 2,3-naphthalene dicarboxaldehyde (NDA) were 
obtained from Sigma-Aldrich (St. Louis, MO, USA). 
The brain GABA and glutamate concentrations were assayed 
by the method of Clarke et al. [23] with slight modifications. 
On the day of the assay, the left brain was weighed and placed 
in a centrifuge tube, followed by the addition of 5 ml of chilled 
homogenization buffer [0.1 M citric acid, 0.1 M sodium 
phosphate monobasic, 5.6 mM octane sulfonic acid and 10 μM 
EDTA in 10% (v/v) methanol solution, pH 2.8 with 4 M NaOH]. 
After homogenization, each sample was centrifuged at 14,000 
rpm for 15 min at 4℃ and the supernatant was stored at -50℃ 
until derivatisation for GABA and glutamate analysis. One mg/ml 
stock standards of GABA and L-glutamate were prepared in 
HPLC grade water and 1 M phosphoric acid, and working 
dilutions were prepared in the tissue homogenization buffer. 
Then, 100 μl of either the standard mix or sample supernatant, 
900 μl of borate buffer (0.1 M, pH 9.5), 200 μl of potassium 
cyanide (10 mM), and 200 μl of NDA (6 mM) were added to 
a microtube and vortex mixed. The reaction was then allowed 
to proceed at room temperature in the absence of light. Next, 
the sample was filtered through a LC 13 mm syringe filter with 
a 0.45 ㎛ PVDF membrane, and 10 μl of the derivative was 
injected onto the HPLC system. For the assay, borate buffer (0.1 
M, pH 9.5 with or adjusted by 4 M NaOH) was stored at room 
temperature for 1 week. Potassium cyanide (10 mM) in HPLC 
grade water was stored at 4℃  for 1 month. 2,3-Naphthalene 
dicarboxaldehyde (6 mM) in HPLC grade methanol was stored 
at 4℃ in an amber bottle for a week. For the HPLC assay, the 
mobile phase was composed of a mixture of 0.1 M sodium 
phosphate dibasic containing 50 μM EDTA (pH 5.3 with 1 M 
phosphoric acid) and HPLC grade methanol (35:65 v/v). The 
mobile phase was filtered and degassed prior to use. The 
compounds were eluted for a 15 min run-time at a flow rate 
of 0.5 ml/min. The fluorescence detector was set at an excitation 
wavelength of 420 nm, an emission wavelength of 489 nm, and 
a PMT gain of 1. 
The HPLC-FLD analysis system consisted of 515 dual pumps, 
a 717 autosampler, and a 2475 fluorescence detector (Waters, 
Milford, MA USA). All samples were injected and separated onto 
a symmetry (4.6 mm i.d. x 150 mm, 5.0 ㎛) reversed phase C18 
column.
Serum assay
For the serum analysis, o –phtalaldehyde (OPA) was obtained 
from ICN Biomedicals, Inc. (Germany). For the serum GABA 
and glutamate analysis, the method was based on that of Vermeij 
and Edelbroek [24] with slight modifications. Briefly, 80 μl of 
serum was placed in 1.5 ml microcentrifuge tubes and 40 μl 
of 20% trichloroacetic acid was added to remove the protein. 
The mixture was mixed for 15s and then centrifuged for 10 min 
at 5,800 rpm. The supernatant was used for analysis.
Borate buffer (0.1 M, pH 10 with NaOH) was stored at room 
temperature for 1 week. A stock solution of OPA was prepared 
by dissolving 100 mg OPA into 3 ml of methanol in an amber 
bottle, and stored at 4℃. A working solution of OPA was 
prepared by adding 300 μl of stock solution and 20 μl of MPA 
to 4 ml of 0.1 M borate buffer (pH 10). 
Fifty microliters of either the standard mix or sample 
supernatant, 500 μl of borate buffer (0.1 M, pH 10), and 50 μl 
of OPA working reagent were added to a microtube, vortex 
mixed, and then left for 1 min to react. The reaction was allowed 
to proceed at room temperature in the absence of light. Next, 
the sample was filtered through a LC 13 mm syringe filter with 
a 0.45 ㎛ PVDF membrane and 10 μl of the sample was injected 
onto the HPLC system. For the serum assay, the mobile phase 
consisted of a mixture of 20 mM potassium phosphate buffer 
(pH 7.0), HPLC grade acetonitrile, and HPLC grade methanol 
(74.5 : 17.5 : 8, v/v). The mobile phase was filtered and degassed 
prior to use. The final pH of the mobile phase was 7.55. The 
compounds were eluted for a 15 min run-time at a flow rate 
of 0.6 ml/min. The fluorescence detector was set at an excitation 
wavelength of 330 nm, an emission wavelength of 450 nm, and 
a PMT gain of 1. 
GABA and glutamate were identified by their retention times 
as determined by standard injections. Sample peak heights were 
measured and compared with the standard curve in order to 
quantify the GABA and glutamate levels.
Statistical analysis
The data were expressed as means ± SEM in each Fig. or Table. 
Analysis of variance was performed on the means to determine 
whether there were significant differences among the groups. 
When analysis of variance indicated statistical significance, 
Duncan’s multiple range test was used to determine which means 
were significantly different. Student’s t-test was used to compare 
the control and γ-PGA supplemented groups. All significance 
levels were set at P < 0.05.
Results
Feed intakes and weight gains
Feed intakes and body weight gains are presented in Table 
2. Feed intakes were not significantly different among the groups. 
The amounts of weight gain of the high fat HC and HP groups 
were significantly higher than those of the normal fat CC and 
CP groups. In addition, the HCC and HCP groups gained 
significantly more weight than the CC and CP groups. The 
supplementation of 0.1% γ-PGA had no effect on weight gain 
even though the weight gains of the CC and HC groups were 
slightly more than those of the CP and HP groups. As shown 
in Fig. 1, the high fat diets, due to their high energy density, 
stimulated weight accumulation. From the third week, the 
weights of the high fat groups were significantly more than those 26 Effect of PGA on glutamate and GABA concentrations
Table 2. Weight gain and feed intake
1
Group Weight gain (g) Feed intake (g/wk)
CC 158.1 ± 14.7
b 179.7 ± 4.5
CP 157.7 ± 16.2
b 175.4 ± 4.1
HC 254.9 ± 15.8
a 165.3 ± 4.9
HP 243.6 ± 14.3
a 174.1 ± 9.9
HCC 210.8 ± 16.2
a 174.6 ± 5.3
HCP 220.9 ± 15.4
a 175.8 ± 3.9
1 CC: 10% fat control, CP: 10% fat with γ-PGA, HC: High fat control, HP: High 
fat  with  γ-PGA,  HCC:  45%  to  10%  fat  control,  HCP:  45%  to  10%  fat  with 
γ -P G A . F eed  intakes are sho w n  the am o u nts d u rin g  γ -P G A  su p p lem entation. 
All  data  are  expressed  as  means ± SEM. 
Different  letters  in  a  column  indicate  significantly  different  values  assessed  by 
Duncan’s  multiple  range  test  (P < 0.05).
Fig. 1. Changes of body weight during the experimental period. CC: 10% fat 
control, CP: 10% fat with γ-PGA, HC: High fat control, HP: High fat with γ-PGA, 
HCC:  45%  to  10%  fat  control,  HCP:  45%  to  10%  fat  with  γ-PGA.  All  points 
represent means, n=10 rats per group. Different letters in the same week indicate 
significantly  different  values  assessed  by  Duncan’s  multiple  range  test  (P < 0.05). 
(A)
(B) 
Fig. 2. Chromatograms of NDA derivatives of glutamate and GABA. (A) Standard 
solution, 10 ug of glutamate (retention time: 3.752 min) and GABA (retention time: 
8.338  min)  injected  onto  the  column.  Conditions  as  described  in t h e  t e x t .  ( B )  
Example of a brain sample from a CP group rat showing glutamate (8.8 mg/g tissue) 
a n d  G A B A  ( 1 . 6  m g / g  t i s s u e ) .
(A)
(B)
Fig. 3. Chromatograms of OPA derivatives of glutamate and GABA. (A) Standard 
solution, 10 ug of glutamate (retention time: 1.833 min) and GABA (retention time: 
2.478  min)  injected  onto  the  column.  Conditions  as  described  in t h e  t e x t .  ( B )  
Example of a serum sample from a CP group rat showing glutamate (9.8 ug/m l) 
a n d  G A B A  ( 6 0 . 4  u g / m l) . 
of the normal fat groups. When the diet composition was 
switched from 45% of kcal to 10% of kcal from fat at the 5
th 
week in the HCC and HCP groups, weight gain was slowly 
increased. However, the weights of the HCC and HCP groups 
were significantly more than those of the CC and CP groups.
Total food consumption was lower in the high fat diet groups 
with or without γ-PGA supplementation than in the normal fat 
CC and CP groups and in a different manner to body weight. 
The energy densitites of the experimental diets were different, 
such as 4.68 kcal/g in the high fat and 3.80 kcal/g in the normal 
fat diet. This indicates that the high fat diet group had higher 
energy intake than the control fat diet group, and the high fat 
diet contributed to a transition to obesity. However, the feed 
intakes of the groups supplemented with γ-PGA were not 
significantly different from those of the groups not supplemented 
with γ-PGA. Our results agree with a study where rats provided 
diets containing 1% γ-PGA showed no differences in feed intake 
[15], while Japanese natto mucilage containing γ-PGA 
significantly decreased feed intake [25]. 
Development and validation of analytical method
Fig. 2 illustrates the chromatograms of brain samples obtained 
using the HPLC-FLD system. The concentrations of glutamate 
and GABA in standard solutions and tissue samples were 
determined by calculating the peak heights. The detector linearity 
of responses to the standard solutions of glutamate and GABA 
were determined. Calibration curves were obtained from a blank Hyesung Lee et al. 27
Table 3. Serum Glutamate and GABA concentraions
1
Group Glutamate
(mg/g tissue)
GABA
(mg/g tissue)
CC 12.76 ± 0.65
ab 66.85 ± 1.25
ab
CP 15.55 ± 1.11
a* 74.95 ± 2.91
a*
HC 12.74 ± 0.87
ab 62.49 ± 1.59
b
HP 11.31 ± 0.81
b 67.06 ± 2.87
ab
HCC 11.83 ± 0.75
b 67.27 ± 2.58
ab
HCP 13.64 ± 1.33
ab 64.56 ± 3.80
b
1 CC: 10% fat control, CP: 10% fat with γ-PGA, HC: High fat control, HP: High 
fat  with  γ-PGA,  HCC:  45%  to  10%  fat  control,  HCP:  45%  to  10%  fat  with 
γ-PGA. 
A ll  d a t a  a r e  e x p r e s s e d  a s  m e a n s±S E M ,  n = 1 0  r a t s  p e r  g r o u p . 
Different  letters  in  a  column  indicate  significantly  different  values  assessed  by 
Duncan’s  multiple  range  test  (P < 0.05). 
Values with * represent significant differences between the control group and the 
γ-PGA  supplemented  group  as  assessed  by  student’s  t-test  (P < 0.05).
Table 4. Brain glutamate and GABA concentrations
1
Group Glutamate
(mg/g tissue)
GABA
(mg/g tissue)
CC 6.85 ± 0.37
c 1.54 ± 0.07
ab
CP 8.45 ± 0.36
b* 1.62 ± 0.06
ab
HC 8.46 ± 0.20
b 1.54 ± 0.03
ab
HP 9.19 ± 0.26
ab* 1.66 ± 0.04
a
HCC 8.96 ± 0.22
ab 1.48 ± 0.03
b
HCP 9.34 ± 0.20
a 1.50 ± 0.04
b
1CC: 10% fat control, CP: 10% fat with γ-PGA, HC: High fat control, HP: High 
fat with γ-PGA, HCC: 45% to 10% fat control, HCP: 45% to 10% fat with γ-PGA. 
A ll  d a t a  a r e  e x p r e s s e d  a s  m e a n s±S E M ,  n = 1 0  r a t s  p e r  g r o u p . 
Different  letters  in  a  column  indicate  significantly  different  values  assessed  by 
Duncan’s  multiple  range  test  (P < 0.05). 
Values with * represent significant differences between the control group and the 
γ-PGA  supplemented  group  as  assessed  by  student’s  t-test  (P < 0.05).
and 5 standard solutions of glutamate and GABA, and the 
correlation coefficients of the curves were not less than 0.98. 
The total run time was 15 min using the assay conditions 
described above. Clarke et al. [23] successfully used NDA 
derivatisation with slight modifications of mobile phase pH in 
conjunction with either fluorescent or electrochemical detection 
systems. They found that a mobile phase pH of 5.6 was most 
suitable for an electrochemical detection system and a pH of 
5.3 was optimum in a fluorescent detection system. The optimum 
reaction time was shown to be 15 min as per the fluorescent 
detection system, which is the same as our runtime. The mean 
elution times for glutamate and GABA were 3.75 min and 8.33 
min, respectively, which are below 5.95 min and 11.45 min [23] 
because our flow rate was faster.
The chromatogram profiles of the OPA derivatives of the 
standard solution and a serum sample are presented in Fig. 3. 
One of the most commonly used derivatising agents is OPA, 
which reacts with primary amines in the presence of a thiol and 
generates fluorescent derivatives. However, we used NDA 
derivatives to analyze glutamate and GABA in the brain tissue 
because thiols have a pungent odor and show instability of the 
derivatives. When we applied the NDA derivatising method with 
the serum, it was difficult to achieve an optimum pH without 
acidic homogenizing buffer. Therefore, OPA was chosen as an 
alternative. HPLC methods using OPA derivatization have been 
widely used for the determination of primary amino acids in 
plasma because of their high sensitivity, simplicity, speed, and 
reliability [24,26]. The derivatives formed by the reaction of OPA 
with amino acids in the presence of 3-mercaptopropionic acid 
are fluorescent [27]. The mean elution times for glutamate and 
GABA were 1.833 and 2.478 min, respectively. 
GABA and glutamate concentrations in serum 
Table 3 shows the effects of γ-PGA on GABA and glutamate 
concentrations in serum. The glutamate and GABA concentra-
tions of the CP group were significantly higher than those of 
the CC group. However, the other groups did not show the same 
tendency. The results suggest that supplementation with 0.1% 
γ-PGA significantly elevated glutamate and GABA concentra-
tions in the rats fed 10% of kcal from fat in the diet. 
GABA and glutamate concentrations in brain tissue
Table 4 represents the effect of γ-PGA on GABA and 
glutamate concentrations in the brain. Supplementation with 
0.1%  γ-PGA resulted in a significant elevation of glutamate 
concentration in the normal fat and high fat groups. Glutamate 
concentrations were higher in the HCP group than in the HCC 
group, but a significant difference was not found. These results 
are similar to those of Wang et al. [28] where oral administration 
of L-glutamine, a precursor of glutamate and GABA, led to 
increased concentrations and release of brain glutamate and 
GABA. The GABA concentrations exhibited the same elevated 
trend as the glutamate concentrations, which was not statistically 
significant. 
Discussion
The purpose of this study was to investigate whether 
supplementation of γ-PGA would increase GABA and glutamate 
concentrations in the brain and serum of rats. It also intended 
to determine whether γ-PGA is effective for obese rats. Obesity, 
a rapidly increasing problem in Korea, was induced by providing 
a diet comprised of 45% of kcal from fat, which was compared 
to a 10% fat diet as the control.
There are numerous data showing that GABA functions in 
suppressing high blood pressure in humans and animals. Several 
studies have reported that GABA-enhanced food products such 
as GABA green tea [29], GABA-tempeh [30], and germinated 
brown rice [31] were effective against hypertension. GABA in 
foods may be absorbed through the intestinal membrane and 
increase the GABA level in serum. Therefore, the presence of 
GABA contributes to a hypotensive effect. This study revealed 
that γ-PGA intake significantly increased serum glutamate and 28 Effect of PGA on glutamate and GABA concentrations
GABA concentrations in the CP group (15.55 ㎍/ml, 74.95 ㎍
/ml) compared to the CC group (12.76 ㎍/ml,
  66.855  ㎍/ml), 
whereas  γ-PGA intake in the high fat group did not reveal a 
tendency for elevation in the serum. The significant increase in 
GABA concentration by γ-PGA intake in this study might prove 
useful to help reduce risks of hypertension and cardiovascular 
disease. To confirm the effectiveness of γ-PGA as a functional 
food component, further experiments for its effects on lowering 
blood pressure in a hypertension model would be needed.
Diet influences sympathetic nervous system activity and dietary 
induced changes in sympathetic activity contribute to changes 
in metabolic rate that accompany changes in dietary intake [20]. 
Insulin-mediated glucose metabolism in the hypothalamus 
provides a link between dietary intake and sympathetic nervous 
system activity. Hyperinsulinemia, a consequence of insulin 
resistance in obese individuals, is associated with hypertension. 
The effects of GABA administered orally might be related to 
its inhibition of noradrenaline release from sympathetic nerve 
fibers [32]. In addition, intracerebroventricular injection of 
GABA (20~200 ㎍) reduced sympathetic nervous activity by 
depressing hypothalamic function and blood pressure in 
spontaneously hypertensive rats [33]. One potential attributable 
mechanism is the fact that GABA hardly passes the blood-brain 
barrier, and this molecule acts not in the central nervous system 
but in the peripheral nervous system [13]. 
Since glutamate is a principal GABA precursor, an increment 
in glutamate level is expected to increase GABA level. Especially 
in the brain, GABA is mostly synthesized from brain glutamates 
because GABA hardly passes the blood-brain barrier [13]. This 
study showed that γ-PGA supplementation significantly 
increased brain glutamate levels in the normal and high fat 
groups, and GABA levels were also increased but not 
significantly. We can not exclude the possibility that higher doses 
and/or a longer duration of γ-PGA supplementation would result 
in significant alterations in brain GABA levels. It has been 
demonstrated that GABA can produce higher levels of human 
growth hormone, which stimulates to lose body fat. Also, GABA 
is known to promote blood circulation and accelerate cell 
metabolism in the brain. The diet-induced obesity in this study 
did not make any difference in brain GABA concentrations in 
spite of significantly elevated brain glutamate levels. Obesity may 
diminish the sensitivity to turn from the precursor glutamate to 
GABA in brain.
Relling et al. [17] reported that obesity resulted in impaired 
cardiomyocyte function. In obesity, levels of the obese gene 
product leptin are often elevated and may contribute to 
cardiovascular complications. High-fat diet-induced obesity leads 
to resistance to leptin-induced cardiomyocyte contractile response 
[11]. Cardiac leptin resistance in diet-induced obesity is possibly 
associated with impaired leptin receptor signaling. The brain has 
evolved mechanisms for sensing and regulating glucose levels 
in the plasma. Glucose infusions activate the sympathetic nervous 
system in rats. However, this activation is dependent upon the 
underlying predisposition of rats to develop diet-induced obesity 
when exposed to a diet relatively high in energy and fat content 
[19]. However, this study confirmed that insensitivity by 
resistance might not be effective in GABA metabolism. 
In summary, this study demonstrated that γ-PGA supplemen-
tation significantly increased serum concentrations of glutamate 
and GABA in control fat diet groups while the effects were not 
shown in high-fat fed obese rats. In the brain, glutamate 
concentrations were significantly higher in the γ-PGA 
supplemented groups both in rats fed the normal and high fat 
diets than in the no γ-PGA controls. GABA concentration 
showed the same tendency. 
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